A nationwide survey of clinical outcome of patients with primary myelofibrosis in Japan

A nationwide survey of clinical outcome of patients with primary myelofibrosis in Japan - A nationwide survey of patients with primary myelofibrosis in Japan

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021946

Enrollment

700

Registered

2016-05-01

Start date

2013-06-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary myelofibrosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are diagnosed as primary myelofibrosis

Exclusion criteria

Exclusion criteria: Reject for enrollment in the study by patients or their family members

Design outcomes

Primary

Measure	Time frame
Survival in patients with primary myelofibrosis in Japan	—

Secondary

Measure	Time frame
Assessment of internationalprognostic models for Japanese patients with primary myelofibrosis	—

Countries

Japan

Contacts

Public ContactKatsuto Takenaka

Kyushu University Hospital Center for Cellular and Molecular Medicine

takenaka@intmed1.med.kyushu-u.ac.jp092-642-5230

Outcome results